<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 21 Jul 2026 16:11:14 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>BTIG Starts Ispire Technology (ISPR) at Buy</title>
   <link>http://www.streetinsider.com/New+Coverage/BTIG+Starts+Ispire+Technology+%28ISPR%29+at+Buy/26795632.html</link>
   <description>(Updated - July 21, 2026 4:11 PM EDT)

&lt;p&gt;BTIG analyst Owen Bennett initiates coverage on Ispire Technology (NASDAQ: ISPR) with a Buy rating and a price target of $3.50.&lt;/p&gt;&lt;p&gt;The analyst comments &quot;With our launch of coverage on ‘Nicotine 2.0’, one of the key differences in this new era is the reliance on nicotine ODM/OEMs across vape, heated and pouches. Ispire is one of those such companies. Being very small right now, the key thesis centers on whether they can capture a growing portion of this huge ODM/OEM market. We believe they are well-placed to do as such. Assuming a (conservative) option</description>
   <guid isPermaLink="true">http://www.streetinsider.com/New+Coverage/BTIG+Starts+Ispire+Technology+%28ISPR%29+at+Buy/26795632.html</guid>
   <pubDate>Tue, 21 Jul 2026 16:11:14 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ISPR</category>
   	  </item>
  <item>
   <title>BTIG Starts Ispire Technology (ISPR) at Buy</title>
   <link>http://www.streetinsider.com/Analyst+Comments/BTIG+Starts+Ispire+Technology+%28ISPR%29+at+Buy/26795632.html</link>
   <description>(Updated - July 21, 2026 4:11 PM EDT)

&lt;p&gt;BTIG analyst Owen Bennett initiates coverage on Ispire Technology (NASDAQ: ISPR) with a Buy rating and a price target of $3.50.&lt;/p&gt;&lt;p&gt;The analyst comments &quot;With our launch of coverage on ‘Nicotine 2.0’, one of the key differences in this new era is the reliance on nicotine ODM/OEMs across vape, heated and pouches. Ispire is one of those such companies. Being very small right now, the key thesis centers on whether they can capture a growing portion of this huge ODM/OEM market. We believe they are well-placed to do as such. Assuming a (conservative) option</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/BTIG+Starts+Ispire+Technology+%28ISPR%29+at+Buy/26795632.html</guid>
   <pubDate>Tue, 21 Jul 2026 16:11:14 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ISPR</category>
   	  </item>
  <item>
   <title>Form  8-K        Ispire Technology Inc.    For: Jul 16</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Ispire+Technology+Inc.++++For%3A+Jul+16/26784718.html</link>
   <description>si-local-file:///var/storage/secattach/20260717/26784718.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Ispire+Technology+Inc.++++For%3A+Jul+16/26784718.html</guid>
   <pubDate>Fri, 17 Jul 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ISPR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57534732</category>
   	  </item>
  <item>
   <title>Form  8-K        Ispire Technology Inc.    For: Jul 16</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Ispire+Technology+Inc.++++For%3A+Jul+16/26784718.html</link>
   <description>si-local-file:///var/storage/secattach/20260717/26784718.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Ispire+Technology+Inc.++++For%3A+Jul+16/26784718.html</guid>
   <pubDate>Fri, 17 Jul 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ISPR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57534732</category>
   	  </item>
  <item>
   <title>Form  8-K        Ispire Technology Inc.    For: Jun 23</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Ispire+Technology+Inc.++++For%3A+Jun+23/26693534.html</link>
   <description>si-local-file:///var/storage/secattach/20260625/26693534.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Ispire+Technology+Inc.++++For%3A+Jun+23/26693534.html</guid>
   <pubDate>Thu, 25 Jun 2026 17:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ISPR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57534732</category>
   	  </item>
  <item>
   <title>Form  8-K        Ispire Technology Inc.    For: Jun 23</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Ispire+Technology+Inc.++++For%3A+Jun+23/26693534.html</link>
   <description>si-local-file:///var/storage/secattach/20260625/26693534.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Ispire+Technology+Inc.++++For%3A+Jun+23/26693534.html</guid>
   <pubDate>Thu, 25 Jun 2026 17:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ISPR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57534732</category>
   	  </item>
  <item>
   <title>Form  DEFA14A    Ispire Technology Inc.               </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Ispire+Technology+Inc.+++++++++++++++/26478604.html</link>
   <description>si-local-file:///var/storage/secattach/20260512/26478604.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Ispire+Technology+Inc.+++++++++++++++/26478604.html</guid>
   <pubDate>Tue, 12 May 2026 16:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ISPR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57534732</category>
   	  </item>
  <item>
   <title>Form  DEFA14A    Ispire Technology Inc.               </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Ispire+Technology+Inc.+++++++++++++++/26478604.html</link>
   <description>si-local-file:///var/storage/secattach/20260512/26478604.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Ispire+Technology+Inc.+++++++++++++++/26478604.html</guid>
   <pubDate>Tue, 12 May 2026 16:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ISPR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57534732</category>
   	  </item>
  <item>
   <title>Form  DEF 14A    Ispire Technology Inc.    For: Jun 23</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++DEF+14A++++Ispire+Technology+Inc.++++For%3A+Jun+23/26478569.html</link>
   <description>si-local-file:///var/storage/secattach/20260512/26478569.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++DEF+14A++++Ispire+Technology+Inc.++++For%3A+Jun+23/26478569.html</guid>
   <pubDate>Tue, 12 May 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ISPR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57534732</category>
   	  </item>
  <item>
   <title>Form  DEF 14A    Ispire Technology Inc.    For: Jun 23</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++DEF+14A++++Ispire+Technology+Inc.++++For%3A+Jun+23/26478569.html</link>
   <description>si-local-file:///var/storage/secattach/20260512/26478569.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++DEF+14A++++Ispire+Technology+Inc.++++For%3A+Jun+23/26478569.html</guid>
   <pubDate>Tue, 12 May 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ISPR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57534732</category>
   	  </item>
  <item>
   <title>Ispire Technology forms joint venture with Jincheng Pharma for nicotine pouches</title>
   <link>http://www.streetinsider.com/Corporate+News/Ispire+Technology+forms+joint+venture+with+Jincheng+Pharma+for+nicotine+pouches/26473706.html</link>
   <description>

&lt;p&gt;Ispire Technology Inc. (NASDAQ: ISPR) announced it has entered into a joint venture with Shandong Jincheng Pharmaceutical Group Co., Ltd. (SZSE: 300233) to manufacture and commercialize nicotine pouch products.&lt;/p&gt;

&lt;p&gt;The partnership marks Ispire's entry into the oral nicotine category, expanding beyond its existing vaping hardware business. According to Grand View Research, the nicotine pouch market was approximately $7 billion in 2025 and is projected to grow at nearly 25% annually through 2033, potentially exceeding $40 billion.&lt;/p&gt;

&lt;p&gt;Under the agreement, Jincheng Pharma will contribute manufacturing equipment, technical expertise, and nicotine pouch materials. The joint venture will leverage Ispire's precision dosing capabilities, regulatory compliance</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Ispire+Technology+forms+joint+venture+with+Jincheng+Pharma+for+nicotine+pouches/26473706.html</guid>
   <pubDate>Tue, 12 May 2026 08:30:23 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">300233</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ISPR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07642199</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57534732</category>
   	  </item>
  <item>
   <title>Ispire Technology forms joint venture with Jincheng Pharma for nicotine pouches</title>
   <link>http://www.streetinsider.com/Corporate+News/Ispire+Technology+forms+joint+venture+with+Jincheng+Pharma+for+nicotine+pouches/26473706.html</link>
   <description>

&lt;p&gt;Ispire Technology Inc. (NASDAQ: ISPR) announced it has entered into a joint venture with Shandong Jincheng Pharmaceutical Group Co., Ltd. (SZSE: 300233) to manufacture and commercialize nicotine pouch products.&lt;/p&gt;

&lt;p&gt;The partnership marks Ispire's entry into the oral nicotine category, expanding beyond its existing vaping hardware business. According to Grand View Research, the nicotine pouch market was approximately $7 billion in 2025 and is projected to grow at nearly 25% annually through 2033, potentially exceeding $40 billion.&lt;/p&gt;

&lt;p&gt;Under the agreement, Jincheng Pharma will contribute manufacturing equipment, technical expertise, and nicotine pouch materials. The joint venture will leverage Ispire's precision dosing capabilities, regulatory compliance</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Ispire+Technology+forms+joint+venture+with+Jincheng+Pharma+for+nicotine+pouches/26473706.html</guid>
   <pubDate>Tue, 12 May 2026 08:30:23 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">300233</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ISPR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07642199</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57534732</category>
   	  </item>
  <item>
   <title>Ispire Technology forms joint venture with Jincheng Pharma for nicotine pouches</title>
   <link>http://www.streetinsider.com/Corporate+News/Ispire+Technology+forms+joint+venture+with+Jincheng+Pharma+for+nicotine+pouches/26473706.html</link>
   <description>

&lt;p&gt;Ispire Technology Inc. (NASDAQ: ISPR) announced it has entered into a joint venture with Shandong Jincheng Pharmaceutical Group Co., Ltd. (SZSE: 300233) to manufacture and commercialize nicotine pouch products.&lt;/p&gt;

&lt;p&gt;The partnership marks Ispire's entry into the oral nicotine category, expanding beyond its existing vaping hardware business. According to Grand View Research, the nicotine pouch market was approximately $7 billion in 2025 and is projected to grow at nearly 25% annually through 2033, potentially exceeding $40 billion.&lt;/p&gt;

&lt;p&gt;Under the agreement, Jincheng Pharma will contribute manufacturing equipment, technical expertise, and nicotine pouch materials. The joint venture will leverage Ispire's precision dosing capabilities, regulatory compliance</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Ispire+Technology+forms+joint+venture+with+Jincheng+Pharma+for+nicotine+pouches/26473706.html</guid>
   <pubDate>Tue, 12 May 2026 08:30:23 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">300233</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ISPR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07642199</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57534732</category>
   	  </item>
  <item>
   <title>Ispire Technology forms joint venture with Jincheng Pharma for nicotine pouches</title>
   <link>http://www.streetinsider.com/Corporate+News/Ispire+Technology+forms+joint+venture+with+Jincheng+Pharma+for+nicotine+pouches/26473706.html</link>
   <description>

&lt;p&gt;Ispire Technology Inc. (NASDAQ: ISPR) announced it has entered into a joint venture with Shandong Jincheng Pharmaceutical Group Co., Ltd. (SZSE: 300233) to manufacture and commercialize nicotine pouch products.&lt;/p&gt;

&lt;p&gt;The partnership marks Ispire's entry into the oral nicotine category, expanding beyond its existing vaping hardware business. According to Grand View Research, the nicotine pouch market was approximately $7 billion in 2025 and is projected to grow at nearly 25% annually through 2033, potentially exceeding $40 billion.&lt;/p&gt;

&lt;p&gt;Under the agreement, Jincheng Pharma will contribute manufacturing equipment, technical expertise, and nicotine pouch materials. The joint venture will leverage Ispire's precision dosing capabilities, regulatory compliance</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Ispire+Technology+forms+joint+venture+with+Jincheng+Pharma+for+nicotine+pouches/26473706.html</guid>
   <pubDate>Tue, 12 May 2026 08:30:23 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">300233</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ISPR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07642199</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57534732</category>
   	  </item>
  <item>
   <title>Ispire Technology Expands Into High-Growth Nicotine Pouch Market Through Strategic Joint Venture with Jincheng Pharma</title>
   <link>http://www.streetinsider.com/Press+Releases/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Partnership combines pharmaceutical-grade manufacturing with Ispire's global platform to accelerate entry into one of the fastest-growing nicotine segments &lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ca.losang&quot; idsrc=&quot;xmltag.org&quot; &gt;LOS ANGELES&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;May 12, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ &lt;b&gt;-- &lt;/b&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4685825-1&amp;amp;h=609010424&amp;amp;u=https%3A%2F%2Fispiretechnology.com%2F&amp;amp;a=Ispire+Technology+Inc.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;b&gt;&lt;span value=&quot;NASDAQ-NMS:ISPR&quot; idsrc=&quot;xmltag.org&quot; &gt;Ispire Technology Inc.&lt;/span&gt;&lt;/b&gt;&lt;/a&gt; (&quot;Ispire&quot; or the &quot;Company&quot;) (&lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4685825-1&amp;amp;h=3905662850&amp;amp;u=https%3A%2F%2Fwww.nasdaq.com%2Fmarket-activity%2Fstocks%2Fispr&amp;amp;a=NASDAQ%3A+ISPR&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;NASDAQ: ISPR&lt;/a&gt;), a trailblazer in vaping technology and precision dosing, announced that it has entered into a joint venture with &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4685825-1&amp;amp;h=3130007742&amp;amp;u=http%3A%2F%2Fwww.jinchengpharm.com%2Fwap_index_en.html&amp;amp;a=Shandong+Jincheng+Pharmaceutical+Group+Co.%2C+Ltd.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;Shenzhen:300233&quot; idsrc=&quot;xmltag.org&quot; &gt;Shandong Jincheng Pharmaceutical Group Co., Ltd.&lt;/span&gt;&lt;/a&gt; (SZSE: 300233) (&quot;Jincheng Pharma&quot;), a global pharmaceutical company, to manufacture and commercialize nicotine pouch products.&lt;/p&gt;&lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder5003&quot;&gt;&lt;p&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://mma.prnewswire.com/media/2771569/Ispire_Technology_Logo.html&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html</guid>
   <pubDate>Tue, 12 May 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">300233</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ISPR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07642199</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57534732</category>
   	  </item>
  <item>
   <title>Ispire Technology Expands Into High-Growth Nicotine Pouch Market Through Strategic Joint Venture with Jincheng Pharma</title>
   <link>http://www.streetinsider.com/Press+Releases/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Partnership combines pharmaceutical-grade manufacturing with Ispire's global platform to accelerate entry into one of the fastest-growing nicotine segments &lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ca.losang&quot; idsrc=&quot;xmltag.org&quot; &gt;LOS ANGELES&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;May 12, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ &lt;b&gt;-- &lt;/b&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4685825-1&amp;amp;h=609010424&amp;amp;u=https%3A%2F%2Fispiretechnology.com%2F&amp;amp;a=Ispire+Technology+Inc.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;b&gt;&lt;span value=&quot;NASDAQ-NMS:ISPR&quot; idsrc=&quot;xmltag.org&quot; &gt;Ispire Technology Inc.&lt;/span&gt;&lt;/b&gt;&lt;/a&gt; (&quot;Ispire&quot; or the &quot;Company&quot;) (&lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4685825-1&amp;amp;h=3905662850&amp;amp;u=https%3A%2F%2Fwww.nasdaq.com%2Fmarket-activity%2Fstocks%2Fispr&amp;amp;a=NASDAQ%3A+ISPR&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;NASDAQ: ISPR&lt;/a&gt;), a trailblazer in vaping technology and precision dosing, announced that it has entered into a joint venture with &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4685825-1&amp;amp;h=3130007742&amp;amp;u=http%3A%2F%2Fwww.jinchengpharm.com%2Fwap_index_en.html&amp;amp;a=Shandong+Jincheng+Pharmaceutical+Group+Co.%2C+Ltd.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;Shenzhen:300233&quot; idsrc=&quot;xmltag.org&quot; &gt;Shandong Jincheng Pharmaceutical Group Co., Ltd.&lt;/span&gt;&lt;/a&gt; (SZSE: 300233) (&quot;Jincheng Pharma&quot;), a global pharmaceutical company, to manufacture and commercialize nicotine pouch products.&lt;/p&gt;&lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder5003&quot;&gt;&lt;p&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://mma.prnewswire.com/media/2771569/Ispire_Technology_Logo.html&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html</guid>
   <pubDate>Tue, 12 May 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">300233</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ISPR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07642199</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57534732</category>
   	  </item>
  <item>
   <title>Ispire Technology Expands Into High-Growth Nicotine Pouch Market Through Strategic Joint Venture with Jincheng Pharma</title>
   <link>http://www.streetinsider.com/Press+Releases/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Partnership combines pharmaceutical-grade manufacturing with Ispire's global platform to accelerate entry into one of the fastest-growing nicotine segments &lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ca.losang&quot; idsrc=&quot;xmltag.org&quot; &gt;LOS ANGELES&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;May 12, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ &lt;b&gt;-- &lt;/b&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4685825-1&amp;amp;h=609010424&amp;amp;u=https%3A%2F%2Fispiretechnology.com%2F&amp;amp;a=Ispire+Technology+Inc.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;b&gt;&lt;span value=&quot;NASDAQ-NMS:ISPR&quot; idsrc=&quot;xmltag.org&quot; &gt;Ispire Technology Inc.&lt;/span&gt;&lt;/b&gt;&lt;/a&gt; (&quot;Ispire&quot; or the &quot;Company&quot;) (&lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4685825-1&amp;amp;h=3905662850&amp;amp;u=https%3A%2F%2Fwww.nasdaq.com%2Fmarket-activity%2Fstocks%2Fispr&amp;amp;a=NASDAQ%3A+ISPR&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;NASDAQ: ISPR&lt;/a&gt;), a trailblazer in vaping technology and precision dosing, announced that it has entered into a joint venture with &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4685825-1&amp;amp;h=3130007742&amp;amp;u=http%3A%2F%2Fwww.jinchengpharm.com%2Fwap_index_en.html&amp;amp;a=Shandong+Jincheng+Pharmaceutical+Group+Co.%2C+Ltd.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;Shenzhen:300233&quot; idsrc=&quot;xmltag.org&quot; &gt;Shandong Jincheng Pharmaceutical Group Co., Ltd.&lt;/span&gt;&lt;/a&gt; (SZSE: 300233) (&quot;Jincheng Pharma&quot;), a global pharmaceutical company, to manufacture and commercialize nicotine pouch products.&lt;/p&gt;&lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder5003&quot;&gt;&lt;p&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://mma.prnewswire.com/media/2771569/Ispire_Technology_Logo.html&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html</guid>
   <pubDate>Tue, 12 May 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">300233</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ISPR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07642199</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57534732</category>
   	  </item>
  <item>
   <title>Ispire Technology Expands Into High-Growth Nicotine Pouch Market Through Strategic Joint Venture with Jincheng Pharma</title>
   <link>http://www.streetinsider.com/Press+Releases/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Partnership combines pharmaceutical-grade manufacturing with Ispire's global platform to accelerate entry into one of the fastest-growing nicotine segments &lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ca.losang&quot; idsrc=&quot;xmltag.org&quot; &gt;LOS ANGELES&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;May 12, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ &lt;b&gt;-- &lt;/b&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4685825-1&amp;amp;h=609010424&amp;amp;u=https%3A%2F%2Fispiretechnology.com%2F&amp;amp;a=Ispire+Technology+Inc.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;b&gt;&lt;span value=&quot;NASDAQ-NMS:ISPR&quot; idsrc=&quot;xmltag.org&quot; &gt;Ispire Technology Inc.&lt;/span&gt;&lt;/b&gt;&lt;/a&gt; (&quot;Ispire&quot; or the &quot;Company&quot;) (&lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4685825-1&amp;amp;h=3905662850&amp;amp;u=https%3A%2F%2Fwww.nasdaq.com%2Fmarket-activity%2Fstocks%2Fispr&amp;amp;a=NASDAQ%3A+ISPR&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;NASDAQ: ISPR&lt;/a&gt;), a trailblazer in vaping technology and precision dosing, announced that it has entered into a joint venture with &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4685825-1&amp;amp;h=3130007742&amp;amp;u=http%3A%2F%2Fwww.jinchengpharm.com%2Fwap_index_en.html&amp;amp;a=Shandong+Jincheng+Pharmaceutical+Group+Co.%2C+Ltd.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;Shenzhen:300233&quot; idsrc=&quot;xmltag.org&quot; &gt;Shandong Jincheng Pharmaceutical Group Co., Ltd.&lt;/span&gt;&lt;/a&gt; (SZSE: 300233) (&quot;Jincheng Pharma&quot;), a global pharmaceutical company, to manufacture and commercialize nicotine pouch products.&lt;/p&gt;&lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder5003&quot;&gt;&lt;p&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://mma.prnewswire.com/media/2771569/Ispire_Technology_Logo.html&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html</guid>
   <pubDate>Tue, 12 May 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">300233</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ISPR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07642199</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57534732</category>
   	  </item>
  <item>
   <title>Ispire Technology Expands Into High-Growth Nicotine Pouch Market Through Strategic Joint Venture with Jincheng Pharma</title>
   <link>http://www.streetinsider.com/PRNewswire/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Partnership combines pharmaceutical-grade manufacturing with Ispire's global platform to accelerate entry into one of the fastest-growing nicotine segments &lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ca.losang&quot; idsrc=&quot;xmltag.org&quot; &gt;LOS ANGELES&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;May 12, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ &lt;b&gt;-- &lt;/b&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4685825-1&amp;amp;h=609010424&amp;amp;u=https%3A%2F%2Fispiretechnology.com%2F&amp;amp;a=Ispire+Technology+Inc.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;b&gt;&lt;span value=&quot;NASDAQ-NMS:ISPR&quot; idsrc=&quot;xmltag.org&quot; &gt;Ispire Technology Inc.&lt;/span&gt;&lt;/b&gt;&lt;/a&gt; (&quot;Ispire&quot; or the &quot;Company&quot;) (&lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4685825-1&amp;amp;h=3905662850&amp;amp;u=https%3A%2F%2Fwww.nasdaq.com%2Fmarket-activity%2Fstocks%2Fispr&amp;amp;a=NASDAQ%3A+ISPR&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;NASDAQ: ISPR&lt;/a&gt;), a trailblazer in vaping technology and precision dosing, announced that it has entered into a joint venture with &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4685825-1&amp;amp;h=3130007742&amp;amp;u=http%3A%2F%2Fwww.jinchengpharm.com%2Fwap_index_en.html&amp;amp;a=Shandong+Jincheng+Pharmaceutical+Group+Co.%2C+Ltd.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;Shenzhen:300233&quot; idsrc=&quot;xmltag.org&quot; &gt;Shandong Jincheng Pharmaceutical Group Co., Ltd.&lt;/span&gt;&lt;/a&gt; (SZSE: 300233) (&quot;Jincheng Pharma&quot;), a global pharmaceutical company, to manufacture and commercialize nicotine pouch products.&lt;/p&gt;&lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder5003&quot;&gt;&lt;p&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://mma.prnewswire.com/media/2771569/Ispire_Technology_Logo.html&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html</guid>
   <pubDate>Tue, 12 May 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">300233</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ISPR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07642199</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57534732</category>
   	  </item>
  <item>
   <title>Ispire Technology Expands Into High-Growth Nicotine Pouch Market Through Strategic Joint Venture with Jincheng Pharma</title>
   <link>http://www.streetinsider.com/PRNewswire/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Partnership combines pharmaceutical-grade manufacturing with Ispire's global platform to accelerate entry into one of the fastest-growing nicotine segments &lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ca.losang&quot; idsrc=&quot;xmltag.org&quot; &gt;LOS ANGELES&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;May 12, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ &lt;b&gt;-- &lt;/b&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4685825-1&amp;amp;h=609010424&amp;amp;u=https%3A%2F%2Fispiretechnology.com%2F&amp;amp;a=Ispire+Technology+Inc.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;b&gt;&lt;span value=&quot;NASDAQ-NMS:ISPR&quot; idsrc=&quot;xmltag.org&quot; &gt;Ispire Technology Inc.&lt;/span&gt;&lt;/b&gt;&lt;/a&gt; (&quot;Ispire&quot; or the &quot;Company&quot;) (&lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4685825-1&amp;amp;h=3905662850&amp;amp;u=https%3A%2F%2Fwww.nasdaq.com%2Fmarket-activity%2Fstocks%2Fispr&amp;amp;a=NASDAQ%3A+ISPR&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;NASDAQ: ISPR&lt;/a&gt;), a trailblazer in vaping technology and precision dosing, announced that it has entered into a joint venture with &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4685825-1&amp;amp;h=3130007742&amp;amp;u=http%3A%2F%2Fwww.jinchengpharm.com%2Fwap_index_en.html&amp;amp;a=Shandong+Jincheng+Pharmaceutical+Group+Co.%2C+Ltd.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;Shenzhen:300233&quot; idsrc=&quot;xmltag.org&quot; &gt;Shandong Jincheng Pharmaceutical Group Co., Ltd.&lt;/span&gt;&lt;/a&gt; (SZSE: 300233) (&quot;Jincheng Pharma&quot;), a global pharmaceutical company, to manufacture and commercialize nicotine pouch products.&lt;/p&gt;&lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder5003&quot;&gt;&lt;p&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://mma.prnewswire.com/media/2771569/Ispire_Technology_Logo.html&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html</guid>
   <pubDate>Tue, 12 May 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">300233</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ISPR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07642199</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57534732</category>
   	  </item>
  <item>
   <title>Ispire Technology Expands Into High-Growth Nicotine Pouch Market Through Strategic Joint Venture with Jincheng Pharma</title>
   <link>http://www.streetinsider.com/PRNewswire/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Partnership combines pharmaceutical-grade manufacturing with Ispire's global platform to accelerate entry into one of the fastest-growing nicotine segments &lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ca.losang&quot; idsrc=&quot;xmltag.org&quot; &gt;LOS ANGELES&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;May 12, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ &lt;b&gt;-- &lt;/b&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4685825-1&amp;amp;h=609010424&amp;amp;u=https%3A%2F%2Fispiretechnology.com%2F&amp;amp;a=Ispire+Technology+Inc.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;b&gt;&lt;span value=&quot;NASDAQ-NMS:ISPR&quot; idsrc=&quot;xmltag.org&quot; &gt;Ispire Technology Inc.&lt;/span&gt;&lt;/b&gt;&lt;/a&gt; (&quot;Ispire&quot; or the &quot;Company&quot;) (&lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4685825-1&amp;amp;h=3905662850&amp;amp;u=https%3A%2F%2Fwww.nasdaq.com%2Fmarket-activity%2Fstocks%2Fispr&amp;amp;a=NASDAQ%3A+ISPR&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;NASDAQ: ISPR&lt;/a&gt;), a trailblazer in vaping technology and precision dosing, announced that it has entered into a joint venture with &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4685825-1&amp;amp;h=3130007742&amp;amp;u=http%3A%2F%2Fwww.jinchengpharm.com%2Fwap_index_en.html&amp;amp;a=Shandong+Jincheng+Pharmaceutical+Group+Co.%2C+Ltd.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;Shenzhen:300233&quot; idsrc=&quot;xmltag.org&quot; &gt;Shandong Jincheng Pharmaceutical Group Co., Ltd.&lt;/span&gt;&lt;/a&gt; (SZSE: 300233) (&quot;Jincheng Pharma&quot;), a global pharmaceutical company, to manufacture and commercialize nicotine pouch products.&lt;/p&gt;&lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder5003&quot;&gt;&lt;p&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://mma.prnewswire.com/media/2771569/Ispire_Technology_Logo.html&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html</guid>
   <pubDate>Tue, 12 May 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">300233</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ISPR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07642199</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57534732</category>
   	  </item>
  <item>
   <title>Ispire Technology Expands Into High-Growth Nicotine Pouch Market Through Strategic Joint Venture with Jincheng Pharma</title>
   <link>http://www.streetinsider.com/PRNewswire/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Partnership combines pharmaceutical-grade manufacturing with Ispire's global platform to accelerate entry into one of the fastest-growing nicotine segments &lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.ca.losang&quot; idsrc=&quot;xmltag.org&quot; &gt;LOS ANGELES&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;May 12, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ &lt;b&gt;-- &lt;/b&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4685825-1&amp;amp;h=609010424&amp;amp;u=https%3A%2F%2Fispiretechnology.com%2F&amp;amp;a=Ispire+Technology+Inc.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;b&gt;&lt;span value=&quot;NASDAQ-NMS:ISPR&quot; idsrc=&quot;xmltag.org&quot; &gt;Ispire Technology Inc.&lt;/span&gt;&lt;/b&gt;&lt;/a&gt; (&quot;Ispire&quot; or the &quot;Company&quot;) (&lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4685825-1&amp;amp;h=3905662850&amp;amp;u=https%3A%2F%2Fwww.nasdaq.com%2Fmarket-activity%2Fstocks%2Fispr&amp;amp;a=NASDAQ%3A+ISPR&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;NASDAQ: ISPR&lt;/a&gt;), a trailblazer in vaping technology and precision dosing, announced that it has entered into a joint venture with &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4685825-1&amp;amp;h=3130007742&amp;amp;u=http%3A%2F%2Fwww.jinchengpharm.com%2Fwap_index_en.html&amp;amp;a=Shandong+Jincheng+Pharmaceutical+Group+Co.%2C+Ltd.&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;Shenzhen:300233&quot; idsrc=&quot;xmltag.org&quot; &gt;Shandong Jincheng Pharmaceutical Group Co., Ltd.&lt;/span&gt;&lt;/a&gt; (SZSE: 300233) (&quot;Jincheng Pharma&quot;), a global pharmaceutical company, to manufacture and commercialize nicotine pouch products.&lt;/p&gt;&lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder5003&quot;&gt;&lt;p&gt;&lt;a target=&quot;_blank&quot; href=&quot;https://mma.prnewswire.com/media/2771569/Ispire_Technology_Logo.html&quot;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Ispire+Technology+Expands+Into+High-Growth+Nicotine+Pouch+Market+Through+Strategic+Joint+Venture+with+Jincheng+Pharma/26473674.html</guid>
   <pubDate>Tue, 12 May 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">300233</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ISPR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.07642199</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57534732</category>
   	  </item>
  <item>
   <title>Form  10-Q       Ispire Technology Inc.    For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Ispire+Technology+Inc.++++For%3A+Mar+31/26454304.html</link>
   <description>si-local-file:///var/storage/secattach/20260507/26454304.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Ispire+Technology+Inc.++++For%3A+Mar+31/26454304.html</guid>
   <pubDate>Thu, 07 May 2026 16:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ISPR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57534732</category>
   	  </item>
  <item>
   <title>Form  10-Q       Ispire Technology Inc.    For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Ispire+Technology+Inc.++++For%3A+Mar+31/26454304.html</link>
   <description>si-local-file:///var/storage/secattach/20260507/26454304.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Ispire+Technology+Inc.++++For%3A+Mar+31/26454304.html</guid>
   <pubDate>Thu, 07 May 2026 16:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ISPR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57534732</category>
   	  </item>
  <item>
   <title>Ispire Technology Inc. (ISPR) Misses Q3 EPS by 13c</title>
   <link>http://www.streetinsider.com/Earnings/Ispire+Technology+Inc.+%28ISPR%29+Misses+Q3+EPS+by+13c/26448173.html</link>
   <description>&lt;p&gt;Ispire Technology Inc. (NASDAQ: ISPR) reported Q3 EPS of ($0.17), $0.13 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $18.4 million.&lt;/p&gt;&lt;p&gt;For earnings history and earnings-related data on Ispire Technology Inc. (ISPR) &lt;a href=&quot;http://www.streetinsider.com/ec_earnings.php?q=ISPR&quot;&gt;click here&lt;/a&gt;.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Earnings/Ispire+Technology+Inc.+%28ISPR%29+Misses+Q3+EPS+by+13c/26448173.html</guid>
   <pubDate>Thu, 07 May 2026 07:19:33 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ISPR</category>
   	  </item>
 </channel>
</rss>
